TD Cowen expressed concerns about valuation. “If Celsius can’t demonstrate a path back to growth, it could end up being ...

Fintel reports that on January 21, 2025, TD Cowen initiated coverage of Forte Biosciences (NasdaqCM:FBRX) with a Buy ...

In a report released today, Ritu Baral from TD Cowen maintained a Buy rating on Tenaya Therapeutics (TNYA – Research Report). The company’s ...

TD Cowen's analysis led to an increase in the price target for Kering (EPA:PRTP) SA (KER:FP) (OTC: PPRUY), boosting it to ...

The rise in targets in recent days, however, pushes the stock toward $360 after UBS Group raised its target on Salesforce and ...

With record earnings and the carrier's 2025 guidance signalling robust demand trends, analysts are bullish on the stock.

Knight-Swift Transportation Holdings Inc (KNX) stock saw a modest uptick, ending the day at $55.29 which represents a slight increase of $0.44 or 0.80% from the prior close of $54.85. The stock opened ...

With a finite number of carriers in most regions, the LTL industry is much more disciplined on pricing than the highly ...

Investors often prefer to invest in shares held by company insiders, as management is typically more aligned with the company’s success and shareholder interests. Currently, insiders own just 0.31% of ...

Beyond the influence of new therapies on drug pricing trends, Cowen’s report also accounted for the effects of legislation ...

The U.S. government on Friday announced a list of 15 prescription medicines targeted for Medicare price negotiations for 2027 ...

Investing.com -- TD Cowen initiated coverage of ConocoPhillips (NYSE:COP) with a "Buy" rating and a $125 price target, noting its vast asset base, low-cost operations, and long-term growth drivers ...